Skip to main content
SpringerLink
Log in

Microsphere Preparation Using the Untoxic Solvent Glycofurol

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

At laboratory scale, the most widely applied methods in therapeutic microencapsulation are based on emulsification using organic solvents. Here, glycofurol was proposed as non-toxic solvent to circumvent these inconveniences using a quasi-emulsion extraction method for the preparation of poly (lactide-co-glycolide) microspheres.

Methods

Matrix polymer and lipophilic drug were dissolved in glycofurol, building the internal phase, and emulsified under stirring into various external phases before microspheres could be obtained and characterized for their pharmacotechnical properties.

Results

Microspheres were spherical with particle diameters around 100 to 200 μm and also showed a monomodal particle size distribution. The internal sponge-like structure was related to an incomplete glycofurol extraction (residual content: 16.9% ± 1.6% of total particle mass), which is, however, no toxicological drawback. The encapsulation rate of several model compounds increased with rising partition coefficient (Ibuprofen: 1.9% ± 0.6%, Ritonavir: 11.2% ± 0.4%, Lopinavir: 14.0% ± 2.2%, Sudan III: 28.3% ± 0.4%) due to the decreasing solubility in the external phase. In-vitro release kinetics were varying from a complete release after 4 h for Ritonavir to 3 weeks for Sudan III.

Conclusion

This new method was confirmed to be suitable for the preparation of microspheres with the use of a non-toxic solvent and to allow for the entrapment of lipophilic actives and their controlled release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

REFERENCES

  1. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA Microparticles. International Journal of Pharmaceutics. 2008;364:298–327.

    CAS  PubMed  Google Scholar 

  2. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21:2475–90.

    CAS  PubMed  Google Scholar 

  3. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of Controlled Release. 2005;102:313–32.

    CAS  PubMed  Google Scholar 

  4. McGinity JW, O’Donnell PB. Preparation of microspheres by the solvent evaporation technique. Advanced Drug Delivery Review. 1997;28:25–42.

    Google Scholar 

  5. Matsumoto A et al. A novel preparation method for PLGA microspheres using non-halogenated solvents. Journal of Controlled Release. 2008;129:223–7.

    CAS  PubMed  Google Scholar 

  6. Lamprecht A et al. Microsphere design for the colonic delivery of 5-fluorouracil. Journal of Controlled Release. 2003;90:313–22.

    CAS  PubMed  Google Scholar 

  7. Residual solvents/ Organic volatile impurities, United States Pharmacopeia 32-NF: chapter 467.

  8. Lösungsmittel-Rückstände, European Pharmacopoeia 6.0/5.04.00.00:869-879.

  9. Bitz C, Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. International Journal of Pharmaceutics. 1996;131:171–81.

    CAS  Google Scholar 

  10. Witschi C, Doelker E. Residual solvents in pharmaceutical products: acceptable limits, influences on physicochemical properties, analytical methods and documented values. European Journal of Pharmaceutics and Biopharmaceutics. 1996;43:215–42.

    Google Scholar 

  11. Klose D, Siepmann F, et al. PLGA-based drug delivery systems: importance of the type of drug and device geometry. International Journal of Pharmaceutics. 2008;354:95–103.

    CAS  PubMed  Google Scholar 

  12. Sah H. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres. Journal of Controlled Release. 1997;129:223–7.

    Google Scholar 

  13. Sah H. Ethyl formate—alternative dispersed solvent useful in preparing PLGA microspheres. International Journal of Pharmaceutics. 2000;195:103–13.

    CAS  PubMed  Google Scholar 

  14. Sah H, Smith MS, Chern RT. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone. Pharmaceutical Research. 1996;13:360–7.

    CAS  PubMed  Google Scholar 

  15. Kranz H, Bodmeier R. A novel in situ forming drug delivery system for controlled parenteral drug delivery. International Journal of Pharmaceutics. 2006;332:107–14.

    PubMed  Google Scholar 

  16. Aubert-Pouёssel A, Venier-Julienne MC, Saulnier P, Sergent M, Benoit JP. Preparation of PLGA microspheres by an emulsion-extraction process using glycofurol as polymer solvent. Pharmaceutical Research. 2004;21:2384–91.

    Google Scholar 

  17. P.J. Weller. Glycofurol. In R.C. Rowe, P.J. Sheskey, and S. C. Owen. Handbook of Pharmaceutical excipients (sixth edition), PhP, London/ Chicago, 2009, pp. 297-299.

  18. Crowther MA, Pilling A, Owen K. The evaluation of glycofurol as a vehicle for use in toxicity studies. Human Experimental Toxicology. 1997;16:406.

    Google Scholar 

  19. Jeffery H, Davis SS, O’Hagan DT. The preparation and characterization of poly (lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharmaceutical Research. 1993;10:362–8.

    CAS  PubMed  Google Scholar 

  20. J.-H. Lee, T.G. Park and Hoo-Kyun Choi. Effect of formulation and processing variables on the characteristics of microspheres for water-soluble drugs prepared by W/O/O double emulsion solvent diffusion method, International Journal of Pharmaceutics 196:75-83 (2000).

    Google Scholar 

  21. H. Zhao, J. Gagnon and Urs O Häfeli. Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres, Biomagnetic Research and Technology 5:2 (2007).

    Google Scholar 

  22. Conti B, Genta I, Modena T, Pavanetto F. Investigation on process parameters involved in polylactide-co-glycolide microsphere preparation. Drug Development and Industrial Pharmacy. 1995;21:615–22.

    CAS  Google Scholar 

  23. Khossravi M et al. Analysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20. Pharmaceutical Research. 2002;19:634–9.

    CAS  PubMed  Google Scholar 

  24. Lamprecht A. J-L. Saumet and J-P. Benoit. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. International Journal of Pharmaceutics. 2004;278:407–14.

    CAS  PubMed  Google Scholar 

  25. M. Nagase, T. Matsueda and Yasuhiko Osaki. Determination of Sudan III, Sudan IV and Sudan Red 7B in water by high performance liquid chromatography after mixing extraction, Analytical Sciences 5:157-160(1989).

    Google Scholar 

  26. Takahashi M et al. Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma. Biological & Pharmaceutical Bulletin. 2005;28:1286–90.

    CAS  Google Scholar 

  27. Beetge E et al. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID’s on their transdermal absorption. International Journal of Pharmaceutics. 2000;193:261–4.

    CAS  PubMed  Google Scholar 

  28. Kasim NA et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Molecular Pharmaceutics. 2004;1:85–96.

    CAS  PubMed  Google Scholar 

  29. http://www.drugbank.ca (accessed 04/10/10).

  30. Garg R, Patel D. Hydrophobicity in the design of P2/P2’ tetrahydropyrimidinone HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 2005;15:3767–70.

    CAS  Google Scholar 

  31. Bhhatarai B, Garg R. From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5, 6-dihydropyran-2-ones HIV-1 protease inhibitors. Bioorganic & Medicinal chemistry. 2005;13:4078–84.

    CAS  Google Scholar 

  32. Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Advanced Drug Delivery Reviews. 1999;39:211–38.

    CAS  PubMed  Google Scholar 

  33. Juarranz A, Horobin RW, Proctor GB. Prediction of in situ fluorescence of histochemical reagents using a structure-staining correlation procedure. Histochemistry. 1986;84:426–31.

    CAS  PubMed  Google Scholar 

  34. Abraham MH, Mital A, Zissimos AM. The lipophilicity of Sudan I and its tautomeric forms. Physical Chemistry Chemical Physics. 2002;4:5748–52.

    CAS  Google Scholar 

  35. Murakami H et al. Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. International Journal of Pharmaceutics. 1999;187:143–52.

    CAS  PubMed  Google Scholar 

  36. Wang S, Guo S. Formation mechanism and release behaviour of poly (epsilon-caprolactone) microspheres containing disodium norcantharidate. European Journal of Pharmaceutics and Biopharmaceutics. 2008;69:1176–81.

    CAS  PubMed  Google Scholar 

  37. Niwa T et al. In vitro drug release behavior of D, L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. Journal of Pharmaceutical Sciences. 1993;83:727–32.

    Google Scholar 

  38. Lamprecht A et al. Design of pH-sensitive microspheres for the colon delivery of the immune suppressive drug tacrolimus. European Journal of Pharmaceutics and Biopharmaceutics. 2004;58:37–43.

    CAS  PubMed  Google Scholar 

  39. Godbee J et al. Role of solvent/non-solvent ratio on microsphere formation using the solvent removal method. Journal of Microencapsulation. 2004;21:151–60.

    CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGEMENTS

Alf Lamprecht is grateful to the “Institut Universitaire de France” for financial support.

Author information

Authors and Affiliations

  1. Laboratory of Pharmaceutical Engineering, University of Franche-Comté, Besançon, France

    Alf Lamprecht

  2. Institute of Pharmacy, Laboratory of Pharmaceutical Engineering, University of Bonn, Gerhard-Domagk-Str. 3, 53121, Bonn, Germany

    Daniela Allhenn & Alf Lamprecht

Authors
  1. Daniela Allhenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alf Lamprecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alf Lamprecht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allhenn, D., Lamprecht, A. Microsphere Preparation Using the Untoxic Solvent Glycofurol. Pharm Res 28, 563–571 (2011). https://doi.org/10.1007/s11095-010-0304-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0304-6

KEY WORDS

Search

Navigation